Rua Bioscience Raises Approximately NZ$1 Million Through Rights Offer

Rua Bioscience confirmed on 20 October that its shareholder rights offer had raised approximately NZ$1 million at an issue price of NZ$0.025 per new share. The capital is intended to support the company’s growth and working-capital needs, providing a recent example of equity fundraising activity in New Zealand’s biotechnology sector.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.